RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Portsmouth, NH · +120 more sites
3 recruiting psoriasis studies with a site in Portsmouth, NH.
Sponsor: Bristol-Myers Squibb
Portsmouth, NH · +120 more sites
Sponsor: Vanda Pharmaceuticals
Portsmouth, NH · +9 more sites
Sponsor: Eli Lilly and Company
Portsmouth, NH · +38 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.